BRIEF-Altimmune announces $14.7 million Series B preferred stock offering

* Altimmune announces $14.7 million Series B preferred stock offering
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.